2014
DOI: 10.1080/09168451.2014.896733
|View full text |Cite
|
Sign up to set email alerts
|

Presence of osteoinductive factors in bovine colostrum

Abstract: New approaches in the treatment of skeletal defects may benefit from the use of soluble biological factors. We previously standardized a derivative of bovine colostrum (SBCD), deprived of casein and fat and rich in cytokines. In the present study, we tested its possible use as an adjuvant in bone healing. SBCD contained factors involved in stromal cell stimulation and differentiation and induced cytokine production from stimulated mesenchymal stem cells (MSCs). In vitro, SBCD promoted proliferation, migration … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 37 publications
(36 reference statements)
0
5
0
Order By: Relevance
“…In vitro osteogenic differentiation was performed at the same conditions described above to run a series of assays aiming at revealing established bone markers, as described elsewhere [25, 26]. …”
Section: Methodsmentioning
confidence: 99%
“…In vitro osteogenic differentiation was performed at the same conditions described above to run a series of assays aiming at revealing established bone markers, as described elsewhere [25, 26]. …”
Section: Methodsmentioning
confidence: 99%
“…In addition to this, bovine colostrum has a content of 40 times more intense than human colostrum (Şahal et al 2018). Various components other than Ig from colostrum can also be purified and used by using various biotechnological methods (Sacerdote et al 2013, Mussano et al 2014.…”
Section: Resultsmentioning
confidence: 99%
“…The second step aimed at identifying a suitable concentration range of bovine colostrum for further assessing its potential protective action in a cell model of DEX-treated osteoblast MC3T3-E1. The concentrations selected were taken from Mussano et al [ 34 ] and were 0.1, 1.0, 2.5, and 5 mg/mL of culture media. After colostrum treatment for 24 h, cell viability was assessed using the MTT assay.…”
Section: Resultsmentioning
confidence: 99%